VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
USNA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
USNAUSANA Health Sciences, Inc.
$14.04$259M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
USNA logo

USANA Health Sciences, Inc.

USNA
NYSE · Packaged Foods
$14.04
At close - Sep 23, 4:00 PM EDT - USD
Market Cap$259M
P/E24.2x
52W High$30.09
Volume145.83K
OverviewTerminalAnalysisFinancialsValuationEarningsBreakoutsOwnership
VCP Research Verdict2026Q1

Margin Compression Challenges USANA's Growth Trajectory

USANA faces a complex outlook characterized by volatile revenue growth and significant operating margin contraction, which dropped from 11.0% in 2023Q4 to 5.5% in 2026Q1. While the company maintains a fortress balance sheet with minimal debt, the recent surge ...

GrowthMixed
ProfitabilityStrained
ValuationExpensive
TechnicalsWeak
Explore valuation models
MARKET ACTION

USNA price & volume

Price trend, volume and key moving averages

Launch Terminal
Loading chart...
Decision Checklist4 Core Signals

What matters now

The signals most likely to change the investment case.

01

Earnings momentum

8/12 Beats

EPS beat 8 of last 12 quarters

02

Valuation risk

+74% Peers

P/E is 74% above peer median

03

Market leadership

RS 14 · Lag

Laggard (Underperforming 86% of market)

04

Weak Trend

Below 200DMA

Price < 200DMA

Next CatalystEstimated earnings · Nov 4

Market performance

Price History →

Trailing total returns as of 9/24/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).

YTD Return
USNA-27.78%
S&P 500 (^GSPC)+12.39%
1-Year Return
USNA-51.64%
S&P 500 (^GSPC)+15.77%
3-Year Return
USNA-76.51%
S&P 500 (^GSPC)+73.05%
5-Year Return
USNA-84.23%
S&P 500 (^GSPC)+67.04%
02

Test the fundamentals

Check whether operating performance supports the current valuation.

VALUATION & INTRINSIC VALUE

Valuation Scenarios

Valuation Analysis
Trailing P/E5Y High
24.2x
Forward P/EExpansion
8.1x
EV/EBITDA0th %ile
1.3x
FCF YieldCash Flow
3.3%

Valuation vs 5-Year History

Multiple Range
Metric
Current
5Y Median
Historical Range
Percentile
P/E
24.2x
16.3x
80th· High
EV/EBITDA
1.3x
6.1x
0th· Low
Price/FCF
30.4x
18.5x
80th· High
Current Multiple
5Y Median (50th %ile)

Intrinsic Value Scenarios

DCF Projection
No DCF Model AvailableIntrinsic value modeling is not supported for this equity.

Growth & profitability

Annual revenue & EPS trend
Revenue
$925M+8.3% YoY
Net income
$11M-74.4% YoY
Free cash flow
$9M-83.3% YoY
Operating margin
5.5%-2.3 pts YoY
ROIC (TTM)8.6%
Avg ROIC 5Y-
ROE (TTM)1.8%
Piotroski Score7 / 9
Financial Statements →
03

Monitor what changed

Recent results and news deserve attention only when they alter the forward view.

OPERATING RESULTS

Recent Earnings

Earnings History
EPS Beat Rate8/12 (67%)
Revenue Beat Rate7/12 (58%)
QuarterEPS (Act vs Est)Revenue (Act vs Est)
Q3 2026Latest
Aug 4, 2026
-$0.07-116.3%
vs $0.43
$223M-5.0%
vs $235M
Q2 2026
May 5, 2026
$0.61+38.6%
vs $0.44
$250M+3.7%
vs $241M
Q1 2026
Feb 17, 2026
$0.60+46.3%
vs $0.41
$226M+0.1%
vs $226M
Q4 2025
Oct 21, 2025
-$0.15-160.0%
vs $0.25
$214M-2.8%
vs $220M
Historical baseline: 12 quarters analyzedGAAP / Adjusted
MARKET COVERAGE

Latest News

5 Stories
Zacks Investment Research·Sep 14, 2026
Implied Volatility Surging for USANA Health Stock Options

Investors need to pay close attention to USNA stock based on the movements in the options market lately.

PRNewsWire·Sep 3, 2026
Protein Pop Launches Protein Pop Balance, a Clear Prebiotic Soda with 15 Grams of Protein and 5 Grams of Fiber

Sip smart with our clear prebiotic soda — a balanced refresher for when you're on the go SALT LAKE CITY, Sept. 3, 2026 /PRNewswire/ -- Rise Wellness announced the launch of Protein Pop Balance, the newest addition to its Protein Pop lineup of clear, ready-to-drink protein beverages.

PRNewsWire·Sep 1, 2026
USANA CEO Kevin Guest Calls on People to Find a Way to Serve Others, Then Act

SALT LAKE CITY, Sept. 1, 2026 /PRNewswire/ -- USANA Health Sciences (NYSE: USNA) Chairman and CEO Kevin Guest is calling on people to make service a more intentional part of their lives with a challenge: find someone who needs help, then act.

PRNewsWire·Aug 17, 2026
USANA Introduces 3-in-1 Protein, Creatine, and Electrolyte Drink Mix

New Clear Protein + Creatine Mix combines three active nutrition essentialswith 10 g of protein, 5 g of creatine, and 600+ mg of electrolytes in just 50calories  SALT LAKE CITY, Aug. 17, 2026 /PRNewswire/ -- Many active adults use separate products for protein, creatine, and hydration—adding cost, complexity, and extra steps to their daily routines. To simplify that routine, USANA Health Sciences (NYSE: USNA) today announced the launch of Clear Protein + Creatine Mix, bringing all three—clear whey protein isolate, micronized creatine monohydrate, and electrolytes—into one refreshing, 50-calorie drink.

Filtered for USANA Health Sciences, Inc.More Headlines
04

Compare before deciding

Benchmark USNA against direct peers instead of judging its metrics in isolation.

Peers Comparison

Key metrics vs top competitors for USANA Health Sciences, Inc. (USNA)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
USNA logoUSNAUSANA Health Sciences, Inc.Current
$14.04$259.22M24.218.28%1.16%1.84%—
NUS logoNUSNu Skin Enterprises, Inc.
$4.61$223.82M1.45-14.26%-15.73%-29.42%—
NATR logoNATRNature's Sunshine Products, Inc.
$12.95$227.72M12.225.67%3.68%10.89%—
NHTC logoNHTCNatural Health Trends Corp.
$1.05$10.95M-13.69-7.42%-4.51%-8%—
HLF logoHLFHerbalife Nutrition Ltd.
$11.99$1.24B5.450.89%3.16%——
PLBY logoPLBYPlayboy, Inc.
$1.08$125.24M-8.314.13%0.23%1.44%—

Compare USNA vs Peers

USANA Health Sciences, Inc. (USNA) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs NUS

Most directly comparable listed peer for USNA.

Scale Benchmark

vs AMZN

Larger-name benchmark to compare USNA against a more recognizable public peer.

Peer Set

Compare Top 5

vs NUS, NATR, NHTC, HLF

05

Keep researching

Verify the primary filings, follow material updates, and answer the remaining questions.

USNA SEC Filings & Documents

USANA Health Sciences, Inc. (USNA) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Aug 4, 2026·SEC

Material company update

May 20, 2026·SEC

Material company update

May 5, 2026·SEC

10-K Annual Reports

2
FY 2026

Mar 16, 2026·SEC

FY 2025

Mar 12, 2025·SEC

10-Q Quarterly Reports

6
FY 2026

Aug 13, 2026·SEC

FY 2026

May 12, 2026·SEC

FY 2025

Nov 5, 2025·SEC

Get notified when USNA posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

USNA Frequently Asked Questions

USANA Health Sciences, Inc. (USNA) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is USANA Health Sciences, Inc.'s revenue?

USANA Health Sciences, Inc. (USNA) reported $913.4M in revenue for fiscal year 2025. This represents a 1511% increase from $56.7M in 1996.

How fast is USANA Health Sciences, Inc. growing?

USANA Health Sciences, Inc. (USNA) grew revenue by 8.3% over the past year. This is steady growth.

Is USNA profitable?

USANA Health Sciences, Inc. (USNA) reported a net loss of $22.2M for fiscal year 2025.

Dividend & Returns
What is USNA's return on equity?

USANA Health Sciences, Inc. (USNA) has a return on equity (ROE) of 1.8%. This is below average, suggesting room for improvement.

What is USANA Health Sciences, Inc.'s free cash flow?

USANA Health Sciences, Inc. (USNA) generated $15.9M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

What if you invested $1,000 in USNA back in 1996?

Total return calculator · dividends reinvested · 30+ years of data

See returns →